TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ATYR

aTyr Pharma, Inc.

Healthcare · Biotechnology

0.305$ -9.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

aTyr Pharma, Inc. (ATYR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 70 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ATYR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
125 121 113 106 92 97 97 102 107 94 80 70
107 103 97 90 76 82 83 87 93 80 68 58
9.8 23 6.8 6.8 11 11 10 17 6.2 11 10 16
102 98 84 78 66 72 76 80 90 79 67 57
2.1 2.4 2.5 1.6 1.8 1.7 1.0 0.5 1.0 0.9 0.5 0.4
27 30 29 25 26 27 22 27 27 27 22 21
13 16 16 12 14 15 11 16 16 15 12 11
1.2 1.3 1.1 1.2 1.2 1.3 1.3 1.3 1.4 1.5 1.5 1.5
2.0 3.5 4.9 1.3 3.9 4.3 1.5 3.9 4.1 3.9 2.8 3.2
98 91 84 82 65 70 75 75 80 67 58 49
-453 -468 -484 -500 -517 -532 -547 -566 -592 -606 -617 -627
58 59 66 72 76 83 86 90 97 98 98 98

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?